JW Pharmaceutical Corporation (001065.KS)

KRW 29450.0

(-1.01%)

Market Cap (In KRW)

548.57 Billion

Revenue (In KRW)

748.52 Billion

Net Income (In KRW)

37 Billion

Avg. Volume

230.00

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
25050.0-33333.332
PE
-
EPS
0.0
Beta Value
0.506
ISIN
KR7001061001
CUSIP
-
CIK
-
Shares
18667101.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Young-Sub Shin
Employee Count
-
Website
https://www.jw-pharma.co.kr
Ipo Date
2005-09-29
Details
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.